Merck & Co revealed job and cost reductions to save $3 billion annually. This decision followed lower second-quarter results. Weak demand f...

India's pharma sector is poised for innovation-led growth, fueled by patent expirations and government support. The ₹5,000-cr PRIP scheme a...

U.S. tariffs on pharmaceuticals are unlikely to immediately raise brand-name drug prices, as drugmakers are expected to absorb initial cost...

Keytruda, a cancer treatment drug, has achieved $25 billion in global sales. Its mechanism boosts the immune system to fight cancer. In Ind...

Today, a generation of expensive Gilead drugs containing the new iteration of tenofovir account for half of the market for HIV treatment an...

"I see the progress made by the Modi administration towards not only ensuring that India can meet the needs of its people in healthcare, bu...